Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MSn experiments

被引:46
作者
Borkar, Roshan M. [1 ,2 ]
Raju, B. [1 ]
Srinivas, R. [1 ,2 ]
Patel, Prashant [2 ]
Shetty, Satheesh Kumar [3 ]
机构
[1] Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500607, Andhra Pradesh, India
[2] Natl Inst Pharmaceut Educ & Res, Hyderabad 500037, Andhra Pradesh, India
[3] US Pharmacopeia India Private Ltd, Res & Dev Lab, Hyderabad 500078, Andhra Pradesh, India
关键词
metoprolol; LC-ESI-MS; MS; degradation products; accurate mass measurements; LIQUID-CHROMATOGRAPHY; PROPRANOLOL; METABOLITES; PLASMA; URINE;
D O I
10.1002/bmc.1721
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, specific and reliable isocratic high-performance liquid chromatography combined with quadrupole time-of-flight electrospray ionization tandem mass spectrometry (LC/Q-TOF-ESI-MS/MS) method has been developed and validated for the identification and characterization of stressed degradation products of metoprolol. Metoprolol, an anti-hypertensive drug, was subjected to hydrolysis (acidic, alkaline and neutral), oxidation, photolysis and thermal stress, as per ICH-specified conditions. The drug showed extensive degradation under oxidative and hydrolysis (acid and base) stress conditions. However, it was stable to thermal, neutral and photolysis stress conditions. A total of 14 degradation products were observed and the chromatographic separation of the drug and its degradation products was achieved on a C18 column (4.6 x 250?mm, 5 mu m). To characterize degradation products, initially the mass spectral fragmentation pathway of the drug was established with the help of MS/MS, MSn and accurate mass measurements. Similarly, fragmentation pattern and accurate masses of the degradation products were established by subjecting them to LC-MS/QTOF analysis. Structure elucidation of degradation products was achieved by comparing their fragmentation pattern with that of the drug. The degradation products DP2 (m/z 153) and DP14 (m/z 236) were matched with impurity B, listed in European Pharmacopoeia and British Pharmacopoeia, and impurity I, respectively. The LC-MS method was validated with respect to specificity, linearity, accuracy and precision. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:720 / 736
页数:17
相关论文
共 14 条
[1]   HPLC quantification of metoprolol with solid-phase extraction for the drug monitoring of pediatric patients [J].
Albers, S ;
Elshoff, JP ;
Völker, C ;
Richter, A ;
Läer, S .
BIOMEDICAL CHROMATOGRAPHY, 2005, 19 (03) :202-207
[2]  
[Anonymous], 2009, BRIT PHARMACOPOEIA, V1, P3933
[3]  
[Anonymous], 2005, EUROPEAN PHARMACOPOE, V5, P2032
[4]  
[Anonymous], 2009, BRIT PHARMACOPOEIA, VII, P3933
[5]  
[Anonymous], 1996, ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1) Current Step 4
[6]   DETERMINATION OF METOPROLOL AND 2 MAJOR METABOLITES IN PLASMA AND URINE BY COLUMN LIQUID-CHROMATOGRAPHY AND FLUOROMETRIC DETECTION [J].
BALMER, K ;
ZHANG, YY ;
LAGERSTROM, PO ;
PERSSON, BA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 417 (02) :357-365
[7]   Simultaneous RP-HPLC Determination of Sotalol, Metoprolol, α-Hydroxymetoprolol, Paracetamol and Its Glucuronide and Sulfate Metabolites in Human Urine [J].
Baranowska, Irena ;
Wilczek, Andrzej .
ANALYTICAL SCIENCES, 2009, 25 (06) :769-772
[8]  
I.H.T. Guideline, 2005, INT C HARM GEN, V1, P1, DOI DOI 10.1007/S11095-007-9511-1
[9]  
ICH, 2003, STAB TEST NEW DRUG S
[10]  
Jasinska M, 2009, ACTA POL PHARM, V66, P697